论文部分内容阅读
目的：探讨肺癌供血动脉起源对介入治疗疗效的影响。方法：（１）回顾性分析５５例肺癌１２９例次供血动脉造影征象；（２）采用供血动脉化疗（ＢＡＩ）或合并栓塞（ＰＡＩ），其中ＢＡＩ３６例，ＢＡＩ＋ＰＡＩ１９例，间隔３～４周。结果：５５例支气管动脉供血，其中２例起源于锁骨下动脉。１０例异常的供血动脉，４例由甲状颈干参与，１例由肋间动脉发出，另５例由胸廓内动脉参与供血。ＢＡＩ与ＰＡＩ总有效率为９６．４％，未发生严重并发症。结论：供血动脉ＢＡＩ与ＰＡＩ是安全、有效、易于操作的治疗肺癌方法。
Objective: To investigate the effect of the origin of arterial feeding artery on the efficacy of interventional therapy. Methods: (1) Retrospective analysis of 129 cases of arterial angiography in 129 cases of lung cancer; (2) Use of arterial chemoembolization (BAI) or combined embolization (PAI), including 36 cases of BAI, 19 cases of BAI+PAI, interval of 3 to 4 weeks. RESULTS: Fifty-five bronchial arteries were supplied, of which 2 cases originated from the subclavian artery. In 10 cases of abnormal blood supply arteries, 4 cases were involved in the thyrocervical trunk, 1 case was caused by the intercostal artery, and 5 cases were involved in blood supply by the internal thoracic artery. The total effective rate of BAI and PAI was 96.4%, and no serious complications occurred. CONCLUSIONS: BAI and PAI in blood supply arteries are safe, effective, and easy to operate methods for treating lung cancer.